Key result
Mild aortic regurgitation linked to ~47% higher major cardiovascular events risk in NSTE-ACS.
Why the study?
Mild aortic regurgitation is frequently detected on routine echocardiography in patients with coronary artery disease, yet its prognostic significance in the high-risk context of NSTE-ACS remained poorly defined.
Does concomitant mild aortic regurgitation increase the risk of major adverse cardiovascular events in patients with non-ST-elevation acute coronary syndrome?
Cohort (n=5,162)
Blinded endpoint adjudication
Yes
Does concomitant mild aortic regurgitation increase the risk of major adverse cardiovascular events in patients with non-ST-elevation acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
In patients with NSTE-ACS, concomitant mild aortic regurgitation is an independent predictor of long-term MACEs (cardiac death, heart failure rehospitalisation, and unplanned revascularisation) and is associated with elevated systemic inflammatory indices and remnant cholesterol.
Background: Non-ST-elevation acute coronary syndrome (NSTE-ACS) remains a leading cause of cardiovascular morbidity and mortality worldwide, making accurate risk stratification beyond conventional clinical parameters a critical need. Mild aortic regurgitation (AR) is frequently detected on routine echocardiography in patients with coronary artery disease, yet its prognostic significance in the high-risk context of NSTE-ACS remains poorly defined. Methods: This multicentre retrospective cohort study included 1,290 patients with NSTE-ACS and mild AR from six tertiary cardiovascular centres in China. Propensity score matching targeting an approximately 1:3 ratio identified 3,872 matched controls without AR or other valvular heart disease. The primary endpoint was major adverse cardiovascular events (MACEs), comprising cardiac death, heart failure rehospitalisation, and unplanned coronary revascularisation, over a median follow-up of 50 months. Results: Covariates included in the propensity-score model were adequately balanced after propensity score matching (absolute standardised mean difference <0.10). Mild AR was associated with higher risks of MACEs (HR = 1.47; 95% CI = 1.26-1.72, P < 0.001), cardiac death (HR = 1.51; 95% CI = 1.13-2.02, P = 0.002), heart failure rehospitalisation (HR = 1.57; 95% CI = 1.12-2.20, P = 0.004), and unplanned coronary revascularisation (HR = 1.34; 95% CI = 1.08-1.67, P = 0.004). After multivariable adjustment, mild AR remained independently associated with MACEs (HR = 1.329; 95% CI = 1.144-1.545, P < 0.001). Mild AR was also associated with higher neutrophil-to-lymphocyte ratio (β = 0.56; 95% CI = 0.37-0.74, P < 0.001), systemic immune-inflammation index (β = 161.73; 95% CI = 119.36-204.10, P < 0.001), and remnant cholesterol (β = 0.21; 95% CI = 0.16-0.26, P < 0.001). Exploratory mediation analyses showed modest statistical indirect associations between mild AR and MACEs (~6.8%) and between mild AR and cardiac death (~10.0%), operating through left atrial diameter. Conclusions: In patients with NSTE-ACS, mild AR was independently associated with MACEs and modest differences in inflammatory indices and remnant cholesterol. Mild AR may, therefore, be a readily available marker for risk stratification in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a cohort in Non-ST-elevation acute coronary syndrome (NSTE-ACS) (n=5,162). Mild aortic regurgitation vs. No aortic regurgitation or other valvular heart disease was evaluated on Major adverse cardiovascular events (MACEs), a composite of cardiac death, heart failure rehospitalisation, and unplanned coronary revascularisation (HR 1.47, 95% CI 1.26-1.72, p=<0.001). Mild aortic regurgitation was independently associated with a higher risk of major adverse cardiovascular events in patients with NSTE-ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: